Fed. Circ. Asked Not To Shift Moderna Vax Patent Case To Gov't

By Ryan Davis · July 16, 2026, 9:20 PM EDT

Drugmakers like Novartis, former federal judges, a startup group and others have urged the Federal Circuit to reject calls to shift liability in a COVID-19 vaccine patent suit against Moderna to...

To view the full article, register now.

Documents

Case Information

Case Title

Arbutus Biopharma Corporation v. Moderna, Inc.

Case Number

26-1581

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

March 30, 2026